GENETIC FACTORS IMPORTANCE IN PARKINSON DISEASE

Authors

  • Akhmadov Jakhongir Akmal ugli Asia International University, Bukhara, Uzbekistan. Author

Keywords:

Parkinson disease, genetics, neurodegeneration, α-synuclein, SNCA, LRRK2, PARK2, PINK1, DJ-1, GBA1, mitochondrial dysfunction, oxidative stress, lysosomal dysfunction, personalized medicine, gene mutations, dopaminergic neurons, Lewy bodies, genome-wide association studies, precision therapy

Abstract

Parkinson disease is the second most common neurodegenerative disorder after Alzheimer disease and represents a major global health challenge. Traditionally considered a sporadic disorder primarily associated with aging and environmental exposure, Parkinson disease is now increasingly recognized as having a strong genetic component. Advances in molecular genetics and genomic technologies have identified numerous genes and genetic variants associated with disease susceptibility, progression, and clinical heterogeneity. Mutations in genes such as SNCA, LRRK2, PARK2, PINK1, DJ-1, and GBA1 have significantly contributed to understanding the molecular pathogenesis of Parkinson disease. These discoveries have revealed critical mechanisms including α-synuclein aggregation, mitochondrial dysfunction, oxidative stress, lysosomal impairment, and neuroinflammation. Genetic studies have also facilitated the development of targeted therapies and personalized medicine approaches.

References

1. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015.

2. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature Reviews Disease Primers. 2017.

3. Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson’s disease. Movement Disorders. 2013.

4. Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson’s disease. Lancet Neurology. 2020.

Downloads

Published

2026-05-21